Stocktoria
Rapport Therapeutics, Inc. RAPP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2024-06-07
Rapport Therapeutics, Inc. statistics & valuation
Market cap$1.9B
P / B4.0×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Return on assets | -21.8% | -24.9% | -22.4% |
| Return on equity | -23.0% | -25.6% | 135.7% |
| Current ratio | 26.17 | 35.34 | 17.14 |
Source: SEC EDGAR filings · CIK 0002012593 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.